Predict your next investment

Angel Investor (Group)
biomedinvestors.com

See what CB Insights has to offer

Investments

1

About Bio/Med Investor Network

The Bio/Med Investor Network was formed in 2014 to address the need for funding in early-stage bioscience and healthcare companies. Network members are accredited angel investors specializing in these fields to provide a high level of scrutiny and guidance for growing companies. The Network is based in Atlanta, Georgia with about 40 investor/members.

Bio/Med Investor Network Headquarter Location

Georgia,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Bio/Med Investor Network News

Bio/Med Investor Network Welcomes First Managing Director

Feb 8, 2017

February 08, 2017 01:58 PM Eastern Standard Time ATLANTA--( BUSINESS WIRE )--The Bio/Med Investor Network (BioMed) today announced the hiring of its first Managing Director, Stephen MacDonald, Ph.D. In this role, he oversees network-wide projects ranging from planning and executing numerous events, marketing campaigns, and coordinating all logistics for the network and its members. A long-time member of the Georgia life sciences community, Dr. MacDonald came to Atlanta in 2000 for a post-doctoral fellowship at Emory University. He has spent most of his career as a registered patent agent and patent consultant with 15 years of experience in the life sciences sector. His experience includes evaluating and prosecuting early stage intellectual property and advising small to large sized companies on patent prosecution, due diligence and commercialization strategy. He also serves as Vice President of Member Relations for Georgia Bio, the state’s life science industry association. His unique background speaking the languages of science, business and law, positions him to engage with Georgia’s life sciences industry and be a highly effective leader of the Bio/Med Investor Network. “As BioMed continues to grow in this very technical and complex life science and medical arena, Stephen’s patent agent background in medical innovation and the sciences will be invaluable to our organization,” said Bob McNally, Executive Committee member and CEO of GeoVax Labs. Dr. MacDonald was an original founder of Georgia Bio’s Emerging Leaders Network and was awarded Georgia Bio’s Emerging Leader of the Year award in 2008. He has chaired the Southeast BIO sponsorship committee since 2014, and has been a board trustee of the Ron Clark Academy and chair of their Board governance subcommittee since 2011. “We are pleased to have Stephen on board with BioMed,” said Frank McDaniel, Chair of the BioMed Board of Directors. “It takes only moments into a conversation with him to be caught up in his infectious enthusiasm for our biosciences community, and his deep understanding for both the art and business of the science.” Dr. MacDonald received his Ph.D. in neuroscience from the University of Manitoba, and conducted post-doctoral research at Emory University School of Medicine. He has an MBA from Georgia State University’s Robinson College of Business. About Bio/Med Investor Network The Bio/Med Investor Network was formed in 2014 to address the need for funding in early-stage bioscience and healthcare companies. Network members are accredited angel investors specializing in these fields to provide a high level of scrutiny and guidance for growing companies. The Network is based in Atlanta, Georgia with about 50 investor/members. More information can be found at www.biomedinvestors.com . Contacts

Bio/Med Investor Network Investments

1 Investments

Bio/Med Investor Network has made 1 investments. Their latest investment was in Accuitis as part of their Angel on March 3, 2015.

CBI Logo

Bio/Med Investor Network Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/20/2015

Angel

Accuitis

$1.75M

Yes

4

Date

3/20/2015

Round

Angel

Company

Accuitis

Amount

$1.75M

New?

Yes

Co-Investors

Sources

4

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.